Aryan Mishra: β-Thalassemia Analyzer – HPLC for Hemoglobinopathy Screening
Aryan Mishra, Sales Executive at Surana Enterprises, shared a post on LinkedIn:
“β-Thalassemia Analyzer: What Does It Actually Do?
A routine CBC can provide important clues, but evaluating β-thalassemia and other hemoglobinopathies may require detailed hemoglobin analysis.
Many dedicated systems use HPLC (High-Performance Liquid Chromatography) to separate and quantify different hemoglobin fractions.
Blood Sample leads to Separation, followed by Detection, Chromatogram, and Result.
Key parameters such as HbA₂ and HbF can provide valuable information during laboratory evaluation.
Why is this technology important?
- Carrier screening
- HbA₂ and HbF quantification
- Hemoglobin variant analysis
- Hemoglobinopathy screening
- Standardized laboratory workflow
Key takeaway: A diagnostic analyzer isn’t just a machine—it is a tool that helps laboratories generate clinically meaningful information.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A